The French-American Chamber of Commerce Proudly Presented the 29th Annual Fête and Innovator Award Ceremony 

Thursday, June 13th, 2019

7:00 PM - 10:30 PM

MonacoLogoColor.png

Kimpton Hotel Monaco

Lafayette Ballroom
433 Chestnut Street
Philadelphia, PA 19106

7PM_FêteFlyer_NoPrice_updated_6-2_web_15

"Philadelphia – the birthplace of the nation, and with the help of companies like Invisible Sentinel, Philadelphia will be know as the birthplace of innovation."

- Jonathan A. Grode, Esq.,  FACC President

nicholas-siciliano (2).jpg

Nicholas Siciliano

Chief Executive Officer

Co-Founder

Invisible Sentinel
bioMérieux

IS_logo_300dpi.jpg

La Fête Featured

Live Music by:

ben-pascal (1).jpg

Ben Pascal

Chief Business Officer

Co-Founder

Invisible Sentinel
bioMérieux

1200px-BioMérieux_logo.svg.png

La Fête Featured 

A Private VIP Champagne Reception for the Honorees, Sponsors & FACC Board Members 

 An International Executive Networking Reception 

The 2019 Innovator Award Presentation

A French-inspired Buffet

Music & Dancing

Casino Games for Fun!

A Raffle to Benefit PhilaFLAM 

La Fête Featured a Silent Auction and Business Card Drawing 

Silent Auction Proceeds Benefited PhilaFLAM, 

A Saturday French School and Charitable Organization

Much Appreciation to Our 2019 Prize Donors

 

Meet Our Guests of Honor and Recipients of the 2019 Innovator Award

 

Nicholas Siciliano
Chief Executive Officer and Co-Founder

Invisible Sentinel - bioMérieux


Dr. Siciliano co-founded Invisible Sentinel in 2006 and was the lead inventor of the Company’s Veriflow technology. In his role as CEO, he sets corporate strategy, including sales and marketing initiatives and the identification of strategic partnerships. He also leads the R&D team, drawing on his more than 15 years of experience in microbiology, immunology, and assay development. He earned a B.S. in Chemistry from Villanova University and a Ph.D. in Immunology & Microbial Pathogenesis from Thomas Jefferson University. Formerly, Nick was a biomedical researcher in bacterial and viral pathogenesis, immunology, microbiology, and oncology, as well as a developer of antibody-based assays and consultant on projects in bacteriology, immunology, and antibody design. He has received several awards including Honoree on the annual “40 under 40” list compiled by the Philadelphia Business Journal to recognize outstanding entrepreneurs and business leaders. He was also a recipient of the 2015 Marcum/Smart CEO Innovator of the Year.

 

Ben Pascal
Chief Business Officer and Co-Founder

Invisible Sentinel - bioMérieux


Mr. Pascal co-founded Invisible Sentinel in 2006. In his role as Chief Business Officer, he focuses on marketing and business development. He also works closely with the Sales function of the Company, helping to define sales strategies, identifying potential clients, supporting system implementation at key corporate accounts, and opening new international markets for the Company. Formerly he was a product developer at B. Braun Medical and the National Institute for Medical Research (London). Ben is an inventor on a corresponding patent to an antibacterial device and team member in the design of a functional cellular vaccine against malaria. He received a BS degree from The George Washington University in Biology and Political Science and an MBA from Lehigh University.

About Invisible Sentinel

Invisible Sentinel, Inc., a global molecular solutions company based in Philadelphia, PA, is dedicated to providing first-in-class microbial detection tools. The company’s platform technologies, Veriflow® & Veripro™ are patent protected, molecular based technologies that integrate molecular diagnostics, antibody and probe design, and immunoassays. Veriflow® technology is currently applied across multiple industries including food safety and beverage quality. The company has commercialized or is developing solutions in other industries, such as healthcare, veterinary services, and environmental/water testing. Each solution requires specific design elements, but retains the inherent advantages of our technology: simplicity, accessibility, and affordability.  For more information, visit http://invisiblesentinel.com/.

About bioMérieux


Pioneering Diagnostics
 

A world leader in the field of in vitro diagnostics for over 55 years, bioMérieux is present in 43 countries and serves more than 160 countries with the support of a large network of distributors. In 2018, revenues reached €2.4 billion, with over 90% of international sales.

bioMérieux provides diagnostic solutions (systems, reagents, software, services) which determine the source of disease and contamination to improve patient health and ensure consumer safety. Its products are mainly used for diagnosing infectious diseases. They are also used for detecting microorganisms in agri-food, pharmaceutical and cosmetic products.

For more information, visit https://www.biomerieux.com/en.

bioMérieux is listed on the NYSE Euronext Paris market (Symbol: BIM – ISIN: FR0013280286).

PRESS RELEASE:  France’s bioMerieux buys West Philly biotech firm for $75 million

Previous Fête Honorees

2018        Heiner Markhoff, Chief Executive Officer, SUEZ - Water Technologies & Solutions

2017        Jérôme Wallut, President, Alstom North America

2016        Hervé Hoppenot, President and Chief Executive Officer, Incyte Corporation

2015        Arnaud Vaissié, Co-founder, Chairman & Chief Executive Officer, International SOS; Chair, CCI France International

2014        Dikembe Mutombo, NBA Legend & Humanitarian

2013        Tom Connelly, Chief Innovation Officer, DuPont

2012        Pierre Brondeau, President, Chief Executive Officer & Chairman of the Board, FMC Corporation

2011        Jean-Pierre Clamadieu, Chairman & Chief Executive Officer, Rhodia S.A. (now Solvay)

2010        Frank Baldino, Jr., Ph.D., Founder, Chairman & Chief Executive Officer, Cephalon Inc. (now  Teva)

2009        Raj L. Gupta, Chairman & Chief Executive Officer, Rohm & Haas Company (now Dow Advanced Materials)

2008        Pierre Dufour, President & Chief Executive Officer, American Air Liquide; Sr. Exec. VP & Director, Air Liquide SA

2007        Jean-François Phelizon, President & Chief Executive Officer, Saint-Gobain Corp.; SVP, Compagnie de Saint-Gobain

2006        Stephen K. Green, Group Chairman, HSBC Holdings plc

2005        Jean-François Dehecq, Chairman & CEO, Sanofi-Aventis Group

2004        Bernard Poussot, President, Wyeth Pharmaceuticals (now Pfizer)

2003        His Excellency Jean-David Levitte, Ambassador of France to the United States

2002        Jean-Pierre Loubinoux, Chairman and CEO, SNCF International

2001        Leonard A. Lauder, Chairman, The Estée Lauder Companies Inc.

2000        Robert Venturi & Denise Scott Brown, Architects & City Planners

1999        Anne d’Harnoncourt, CEO, & Joseph Rishel, Curator, Philadelphia Museum of Art/Rodin Museum
1998        Bruno Bonduelle, Chair & CEO, Groupe Bonduelle; President, Lille/Nord-Pas de Calais Development
1997        Jean-Pierre Garnier, President & COO, SmithKlineBeecham (now GSK)
1996        Jean-Daniel Tordjman, Ambassador at Large for Int’l. Investment, Invest in France Mission
1995        Pierre Salinger, Consultant, Author, Journalist; Press Secretary to Presidents Kennedy and Johnson

1994        Serge Bellanger, President, FACC National & NY Chapter; EVP & General Manager, CIC, NY

1993        Madame Georges Pompidou, First Lady of France; Champion of the Elderly & Handicapped
1992        Jean-Daniel Tordjman, Minister Economic & Commercial Affairs, Embassy of France, Washington, DC
1991        His Excellency Jacques Andréani, Ambassador of France to the United States

1990        Bernard D. Azoulay, Chief Operating Officer, Elf Atochem North America, Inc. (now Arkema)

Copyright © 2020 FACC Philadelphia All Rights Reserved